BioSpace News Archive

Getting life scientist jobs can be your best decision ever. Why? It offers endless opportunities, job satisfaction, security, and competitive pay and much more.

Ardelyx said doses of tenapanor, which inhibits controls serum phosphorus by inhibiting the sodium hydrogen exchanger 3 (NHE3), demonstrated a statistically significant reduction in serum phosphorus levels for dialysis patients whose hyperphosphatemia was not previously controlled with phosphate binders alone.

Companies from across Europe and Asia share updates on their business and pipelines.

Researchers from The Westmead Institute for Medical Research have discovered how fatty liver disease develops in lean people, aiding the development of potential treatments for these patients.

Valo Therapeutics Limited announced that it has licensed proprietary PeptiENVTM technology from Helsinki University that enables the coating of enveloped viruses by neoantigen-peptides.

World-renowned drug discovery experts to advance C4XD capabilities

Bristol-Myers will become a limited partner, investing in projects of mutual interest, with an option to buy the companies once there is a preclinical candidate.

Researchers at Temple University Health System have shown that a type of energy malfunction, called mitochondrial calcium transport remodeling, is involved in the progression of Alzheimer’s disease.

Citing unnamed sources “familiar with the matter,” Reuters said that the company will have no choice but to file for bankruptcy should a settlement not be agreed upon.

In the BioSpace poll, 55.17% of respondents said, Yes, companies should be allowed to sue competitors to prevent generic versions of their drugs, and 41.38% said no. A much smaller group, 3.45%, said they were unsure.